Total Payments
$72,112
2024 Payments
$5,028
Companies
44
Transactions
707
Medicare Patients
13,088
Medicare Billing
$617,190
Payment Breakdown by Category
Other$44,901 (62.3%)
Food & Beverage$19,611 (27.2%)
Travel$5,419 (7.5%)
Consulting$2,100 (2.9%)
Education$82.29 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,901 | 21 | 62.3% |
| Food and Beverage | $19,611 | 641 | 27.2% |
| Travel and Lodging | $5,419 | 35 | 7.5% |
| Consulting Fee | $2,100 | 1 | 2.9% |
| Education | $82.29 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $53,140 | 104 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $3,652 | 36 | $0 (2024) |
| United Therapeutics Corporation | $3,476 | 59 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,854 | 88 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,228 | 63 | $0 (2024) |
| PFIZER INC. | $1,183 | 50 | $0 (2024) |
| Amgen Inc. | $1,147 | 43 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $757.26 | 37 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $630.95 | 21 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $605.63 | 44 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,028 | 81 | Actelion Pharmaceuticals US, Inc. ($2,683) |
| 2023 | $1,717 | 68 | Actelion Pharmaceuticals US, Inc. ($339.20) |
| 2022 | $1,149 | 46 | United Therapeutics Corporation ($245.08) |
| 2021 | $859.93 | 22 | United Therapeutics Corporation ($481.33) |
| 2020 | $7,826 | 36 | Amarin Pharma Inc. ($6,987) |
| 2019 | $48,069 | 164 | Amarin Pharma Inc. ($45,348) |
| 2018 | $3,461 | 139 | Amarin Pharma Inc. ($550.53) |
| 2017 | $4,003 | 151 | United Therapeutics Corporation ($650.33) |
All Payment Transactions
707 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $19.47 | General |
| 12/03/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: DIABETES | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/29/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $147.00 | General |
| 10/23/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $39.12 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/07/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $162.97 | General |
| Category: Renal Denervation System | ||||||
| 09/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $41.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $34.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $28.52 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: DIABETES | ||||||
| 09/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiology | ||||||
| 08/30/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $75.10 | General |
| Category: AVVIGO_IC | ||||||
| 08/29/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $103.13 | General |
| 08/28/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.20 | General |
| Category: DIABETES | ||||||
| 08/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Cardio-pulmonary | ||||||
| 08/20/2024 | Penumbra, Inc. | Indigo System (Device) | Food and Beverage | Cash or cash equivalent | $149.36 | General |
| Category: Peripheral Intervention | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,069 | 3,755 | $496,805 | $143,238 |
| 2022 | 26 | 3,824 | 4,842 | $497,371 | $169,671 |
| 2021 | 23 | 3,474 | 4,356 | $437,301 | $165,071 |
| 2020 | 20 | 2,721 | 3,290 | $378,304 | $139,210 |
Total Patients
13,088
Total Services
16,243
Medicare Billing
$617,190
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 263 | 356 | $99,306 | $30,710 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 162 | 207 | $79,935 | $27,537 | 34.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 319 | 321 | $74,651 | $17,118 | 22.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 97 | 178 | $45,897 | $16,895 | 36.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 130 | 171 | $30,688 | $10,848 | 35.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,288 | 1,642 | $42,692 | $10,100 | 23.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 59 | 59 | $26,681 | $7,696 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $19,256 | $6,629 | 34.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 67 | 67 | $17,353 | $3,862 | 22.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 248 | 260 | $15,080 | $2,698 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $7,472 | $2,261 | 30.3% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 16 | 16 | $10,048 | $1,324 | 13.2% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 72 | 73 | $4,234 | $1,196 | 28.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 14 | 14 | $9,382 | $1,112 | 11.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 93 | 94 | $4,324 | $1,014 | 23.4% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 37 | 37 | $3,478 | $734.08 | 21.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 15 | 27 | $1,358 | $468.50 | 34.5% |
| 85610 | Blood test, clotting time | Office | 2023 | 35 | 77 | $1,540 | $323.40 | 21.0% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 21 | 21 | $1,302 | $278.12 | 21.4% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 11 | 12 | $924.00 | $212.41 | 23.0% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 21 | 21 | $420.00 | $119.91 | 28.6% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 41 | 42 | $784.00 | $102.90 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 282 | 415 | $96,882 | $36,847 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 153 | 209 | $65,943 | $28,085 | 42.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 368 | 369 | $59,864 | $19,379 | 32.4% |
About Dr. Dhaval Patel, M.D
Dr. Dhaval Patel, M.D is a Interventional Cardiology healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831151174.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dhaval Patel, M.D has received a total of $72,112 in payments from pharmaceutical and medical device companies, with $5,028 received in 2024. These payments were reported across 707 transactions from 44 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,901).
As a Medicare-enrolled provider, Patel has provided services to 13,088 Medicare beneficiaries, totaling 16,243 services with total Medicare billing of $617,190. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Nuclear Cardiology, Nuclear Imaging & Therapy
- Location Marietta, GA
- Active Since 04/03/2006
- Last Updated 02/05/2026
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1831151174
Products in Payments
- Vascepa (Drug) $53,140
- OPSUMIT (Drug) $2,593
- ORENITRAM (Drug) $1,713
- ENTRESTO (Drug) $1,547
- XARELTO (Drug) $1,228
- ELIQUIS (Drug) $1,210
- UPTRAVI (Drug) $670.93
- Adempas (Drug) $523.78
- Repatha (Biological) $416.45
- PRADAXA (Drug) $404.28
- VERQUVO (Drug) $315.47
- LEQVIO (Drug) $306.60
- PRALUENT (Drug) $287.70
- OPSUMIT MACITENTAN (Drug) $287.55
- BRILINTA (Drug) $285.32
- VYNDAQEL (Drug) $269.96
- JARDIANCE (Drug) $252.37
- Corlanor (Drug) $251.09
- LifeVest (Device) $212.63
- NORTHERA (Drug) $203.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Marietta
Dr. George Kramer, M.d, M.D
Interventional Cardiology — Payments: $109,834
Interventional Cardiology $109,834
John Goddard, M.d, M.D
Interventional Cardiology — Payments: $9,236
Interventional Cardiology $9,236
Dr. Amol Bapat, M.d, M.D
Interventional Cardiology — Payments: $5,920
Interventional Cardiology $5,920
Nabil Sabbak, Md, MD
Interventional Cardiology — Payments: $5,272
Interventional Cardiology $5,272
Cheryl Robertson, M.d, M.D
Interventional Cardiology — Payments: $3,707
Interventional Cardiology $3,707
Jagdesh Kandala, Md, MD
Interventional Cardiology — Payments: $1,574
Interventional Cardiology $1,574